Literature DB >> 20938712

Comparison of lung accumulation of cationic liposomes in normal rats and LPS-treated rats.

Susanne Herber-Jonat1, Rashmi Mittal, Stefan Gsinn, Hermann Bohnenkamp, Eric Guenzi, Andreas Schulze.   

Abstract

OBJECTIVE: Cationic liposomes have been shown to target angiogenic endothelial cells in lungs and joints with evidence of chronic inflammation. We sought to determine whether cationic liposomes accumulate in acutely inflamed lung tissue. SUBJECTS, TREATMENT AND METHODS: Acute lung injury was induced by intratracheal instillation of lipopolysaccharide (LPS) in Sprague Dawley rats. The controls received saline. Following instillation, the rats were ventilated for 5 h. Four hours after LPS-instillation each rat received rhodamine-labeled, cationic liposomes intravenously. The liposomes were allowed to circulate for 1 h. Thereafter, a bronchoalveolar lavage (BAL) was done and the lungs were perfused with saline and formalin. Accumulation of liposomes was assessed by quantitative confocal microscopy and determination of rhodamine-content in lung tissue.
RESULTS: LPS induced a significant increase in BAL white blood cell count (3,444 ± 1,420 vs. 1,314 ± 906*10(3)/μl) and cytokines (IL-1β: 145.57 vs. 51.94 pg/ml; TNF-α: 3,467.5 vs. 42.1 pg/ml) as compared to controls. Cationic liposomes exhibited an accumulation up to twofold in the inflamed lung tissue as compared to healthy lungs (fluorescent pixels 2.93 vs. 1.90(%)).
CONCLUSIONS: Our findings indicate that cationic liposomes accumulate in the acutely inflamed lung tissue. This uptake raises the possibility of using cationic liposomes to direct diagnostic/therapeutic agents selectively to the sites of acute inflammation in the lung.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20938712     DOI: 10.1007/s00011-010-0260-y

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  33 in total

Review 1.  Nonventilatory treatments for acute lung injury and ARDS.

Authors:  Carolyn S Calfee; Michael A Matthay
Journal:  Chest       Date:  2007-03       Impact factor: 9.410

Review 2.  Regulators of endothelial and epithelial barrier integrity and function in acute lung injury.

Authors:  Rudolf Lucas; Alexander D Verin; Stephen M Black; John D Catravas
Journal:  Biochem Pharmacol       Date:  2009-02-03       Impact factor: 5.858

Review 3.  Radiological imaging in acute lung injury and acute respiratory distress syndrome.

Authors:  Pietro Caironi; Eleonora Carlesso; Luciano Gattinoni
Journal:  Semin Respir Crit Care Med       Date:  2006-08       Impact factor: 3.119

4.  Anti-inflammatory activity of cationic lipids.

Authors:  M C Filion; N C Phillips
Journal:  Br J Pharmacol       Date:  1997-10       Impact factor: 8.739

5.  Effect of the surface charge of liposomes on their uptake by angiogenic tumor vessels.

Authors:  Senat Krasnici; Alexander Werner; Martin E Eichhorn; Marcus Schmitt-Sody; Sascha A Pahernik; Birgitta Sauer; Brita Schulze; Michael Teifel; Uwe Michaelis; Kurt Naujoks; Marc Dellian
Journal:  Int J Cancer       Date:  2003-07-01       Impact factor: 7.396

6.  Importance of the liposomal cationic lipid content and type in tumor vascular targeting: physicochemical characterization and in vitro studies using human primary and transformed endothelial cells.

Authors:  Sudhir Dabbas; Ritu R Kaushik; Suman Dandamudi; Geoffrey M Kuesters; Robert B Campbell
Journal:  Endothelium       Date:  2008 Jul-Aug

7.  Neovascular targeting chemotherapy: encapsulation of paclitaxel in cationic liposomes impairs functional tumor microvasculature.

Authors:  Sebastian Strieth; Martin E Eichhorn; Birgitta Sauer; Brita Schulze; Michael Teifel; Uwe Michaelis; Marc Dellian
Journal:  Int J Cancer       Date:  2004-05-20       Impact factor: 7.396

8.  Suppression of endotoxin-induced inflammation by taxol.

Authors:  T Mirzapoiazova; I A Kolosova; L Moreno; S Sammani; J G N Garcia; A D Verin
Journal:  Eur Respir J       Date:  2007-05-30       Impact factor: 16.671

9.  Reactive oxygen species play a central role in the activity of cationic liposome based cancer vaccine.

Authors:  Weili Yan; Weihsu Chen; Leaf Huang
Journal:  J Control Release       Date:  2008-05-15       Impact factor: 9.776

Review 10.  Endothelial pathomechanisms in acute lung injury.

Authors:  Nikolaos A Maniatis; Anastasia Kotanidou; John D Catravas; Stylianos E Orfanos
Journal:  Vascul Pharmacol       Date:  2008-07-29       Impact factor: 5.773

View more
  7 in total

Review 1.  Endothelial nanomedicine for the treatment of pulmonary disease.

Authors:  Jacob S Brenner; Colin Greineder; Vladimir Shuvaev; Vladimir Muzykantov
Journal:  Expert Opin Drug Deliv       Date:  2014-11-14       Impact factor: 6.648

2.  Mechanisms that determine nanocarrier targeting to healthy versus inflamed lung regions.

Authors:  Jacob S Brenner; Kartik Bhamidipati; Patrick M Glassman; N Ramakrishnan; Depeng Jiang; Andrew J Paris; Jacob W Myerson; Daniel C Pan; Vladimir V Shuvaev; Carlos H Villa; Elizabeth D Hood; Raisa Kiseleva; Colin F Greineder; Ravi Radhakrishnan; Vladimir R Muzykantov
Journal:  Nanomedicine       Date:  2017-01-05       Impact factor: 5.307

Review 3.  Nanomedicine for acute respiratory distress syndrome: The latest application, targeting strategy, and rational design.

Authors:  Qi Qiao; Xiong Liu; Ting Yang; Kexin Cui; Li Kong; Conglian Yang; Zhiping Zhang
Journal:  Acta Pharm Sin B       Date:  2021-05-07       Impact factor: 11.413

4.  In vivo imaging of choroidal angiogenesis using fluorescence-labeled cationic liposomes.

Authors:  Jing Hua; Nikolai Gross; Brita Schulze; Uwe Michaelis; Hermann Bohnenkamp; Eric Guenzi; Lutz L Hansen; Gottfried Martin; Hansjürgen T Agostini
Journal:  Mol Vis       Date:  2012-04-26       Impact factor: 2.367

Review 5.  Nanotherapeutics in the treatment of acute respiratory distress syndrome.

Authors:  Pragya Prasanna; Shweta Rathee; Arun Upadhyay; Sulakshana Sulakshana
Journal:  Life Sci       Date:  2021-03-27       Impact factor: 6.780

6.  Choroidal neovascularization reduced by targeted drug delivery with cationic liposome-encapsulated paclitaxel or targeted photodynamic therapy with verteporfin encapsulated in cationic liposomes.

Authors:  Nikolai Gross; Mahdy Ranjbar; Charlotte Evers; Jing Hua; Gottfried Martin; Brita Schulze; Uwe Michaelis; Lutz L Hansen; Hansjürgen T Agostini
Journal:  Mol Vis       Date:  2013-01-10       Impact factor: 2.367

7.  Periodontitis, Microbiomes and their Role in Alzheimer's Disease.

Authors:  Anna B Pritchard; StJohn Crean; Ingar Olsen; Sim K Singhrao
Journal:  Front Aging Neurosci       Date:  2017-10-24       Impact factor: 5.750

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.